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DObjective: Age, preoperative creatinine value, and ejection fraction are easily arranged in the age, creatinine,
ejection fraction score to predict operative mortality in elective cardiac operations, as recently shown. We val-
idate the age, creatinine, ejection fraction score in a large multicentric study.
Methods:We analyzed 29,659 consecutive patients who underwent elective cardiac operations in 14 Italian in-
stitutions during the period from 2004 to 2009. The operative (30-day) mortality rate was recorded for the entire
population and for subgroups of patients based on the risk distribution. The predicted mortality was assessed
using the additive and logistic European System for Cardiac Operative Risk Evaluations, and the age, creatinine,
ejection fraction score. Accuracy and clinical performance of the different models were tested.
Results: The observed mortality rate was 2.77% (95% confidence interval, 2.59–2.96). The predicted mortality
rate was 2.84% (95% confidence interval, 2.79–2.88) for the age, creatinine, ejection fraction score (not signif-
icantly different from the observed rate), 6.26% for the additive European System for Cardiac Operative Risk
Evaluation, and 9.67% for the logistic European System for Cardiac Operative Risk Evaluation (both signifi-
cantly overestimated). For all deciles of risk distribution, the European System for Cardiac Operative Risk Eval-
uation significantly overestimated mortality risk; the age, creatinine, ejection fraction score slightly
overestimated the mortality risk in very low-risk patients and significantly underestimated the mortality risk
in very high-risk patients, correctly estimating the risk in 7 of 10 deciles. The accuracy of the age, creatinine,
ejection fraction score was acceptable (area under the curve of 0.702). In a separate analysis, this value increased
to 0.74 by excluding centers that reported no operative mortality. These values were similar or worse for the
European System for Cardiac Operative Risk Evaluation.
Conclusions: The age, creatinine, ejection fraction score provides an accuracy level comparable to that of the
European System for Cardiac Operative Risk Evaluation, with far superior clinical performance. (J Thorac Car-
diovasc Surg 2011;142:581-6)Earn CME credits at
http://cme.ctsnetjournals.org
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The Journal of Thoracic and Casurgery is burdened by a considerable use of financial and
human resources, and the problem of mortality risk stratifi-
cation is becoming increasingly important.
The age, creatinine, ejection fraction (ACEF) risk score
for operative mortality in patients undergoing elective car-
diac surgery was proposed by Ranucci and coworkers1 in
2009. This score is based on 3 factors only: age, preopera-
tive creatinine value, and ejection fraction (EF). The main
characteristic of this score is the use of age and EF as con-
tinuous variables; the ratio between age (years) and EF (%)
constitutes the basic calculation; an additional point is
added if the preoperative creatinine value exceeds 2.0 mg/
dL. The ACEF score was developed and validated in pa-
tients undergoing elective cardiac surgery (excluding
patients with congenital heart disease) in a single institu-
tion. When compared with other existing risk scores (addi-
tive and logistic euroSCOREs, Parsonnet, Northern New
England, Cleveland Clinic), the ACEF score provides com-
parable or better accuracy values, with improved calibration
and clinical performance.1 The ACEF score was recently2rdiovascular Surgery c Volume 142, Number 3 581
Abbreviations and Acronyms
ACEF ¼ age, creatinine, ejection fraction
AUC ¼ area under the curve
CI ¼ confidence interval
EF ¼ ejection fraction
euroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
PROM ¼ predicted risk of mortality
STS ¼ Society of Thoracic Surgeons
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Syntax score was more accurate in predicting outcome after
coronary angioplasty.
Until now, no external validation studies comparing the
ACEF score with the euroSCORE have been published.
The present study aims to validate the ACEF score and to
compare it with the euroSCORE in terms of accuracy and
clinical performance in a large series of Italian patients
who underwent elective cardiac surgery in 14 Italian insti-
tutions between 2004 and 2009.
MATERIALS AND METHODS
Fourteen Italian institutions contributed to this study: IRCCS Policli-
nico S. Donato, Milan; Universita Vita-Salute San Raffaele, Milan; Anthea
Hospital, Bari; Citta di Lecce Hospital, Lecce; Villa Maria Cecilia Hospi-
tal, Cotignola; Villa Azzurra Hospital, Rapallo; Villa Maria Pia Hospital,
Torino; Villa Maria Eleonora Hospital, Palermo; Villa Maria Beatrice Hos-
pital, Firenze; Salus Hospital, Reggio Emilia; Policlinico Le Scotte, Siena;
Azienda Ospedaliera Universitaria Pisana, Pisa; Fondazione Poliambu-
lanza Istituto Ospedaliero, Brescia; and European Hospital, Rome.
The study was approved by the local ethics committee or the institu-
tional review board of the participating institutions; given the retrospective
nature of data collection based on existing databases, the need for an in-
formed consent was waived.
Data were prospectively collected in local databases at each institution
since 2004. The start date of data collection differed from institution to in-
stitution. All the institutions contributed at least 300 cases per year. Data
collected at the IRCCSPoliclinicoS.Donato includedonly patientswhoun-
derwent operation after October 2008. Data from the GVM hospitals (An-
thea Hospital, Bari; Citta di Lecce Hospital, Lecce; Villa Maria Cecilia
Hospital, Cotignola; Villa Azzurra Hospital, Rapallo; Villa Maria Pia Hos-
pital, Torino; Villa Maria Eleonora Hospital, Palermo; Villa Maria Beatrice
Hospital, Firenze; and Salus Hospital, Reggio Emilia) were collected in
a single, centralized database. These parameters excluded the patient pop-
ulation used to develop and internally validate the ACEF score in the first
study.1 All the institutions routinely and prospectively collected patient
data and stratified the operative mortality risk using the additive3 and logis-
tic4 euroSCOREs. The information needed to calculate the euroSCOREwas
collected routinely as part of clinical care and follow-up by surgeons, anes-
thesiologists, and intensivists, according to the local policies. Operative
mortality information was obtained by telephone contact with the patient
and family members, and a medical practitioner. Operative mortality was
defined according to the Society of Thoracic Surgeons (STS) definition,
as mortality including (1) all deaths occurring during the hospitalization
in which the operation was performed, even if after 30 days; and (2) those
deaths occurring after discharge from the hospital, but within 30 days of
the procedure unless the cause of death is clearly unrelated to the operation.582 The Journal of Thoracic and Cardiovascular SurgAmong the fields used to calculate the euroSCORE, age, preoperative
creatinine value, and left ventricular EF were available to calculate the
ACEF score.
Each institution contributed to the general data collection with a mini-
mum of 307 to a maximum of 6432 cases. All the cases were collected
consecutively at each institution.
Patients were excluded if they were aged less than 18 years, had congen-
ital heart disease, were nonelective (euroSCORE fields: critical preopera-
tive state, emergency, surgery of acute ventricular septal defect), or were
undergoing cardiac transplantation.
The initial dataset comprised 30,231 patients. Follow-up was completed
in 98.1% (range 96.9%–99.3% per institution) of the patients discharged
from the hospital, leading to a total of 29,659 patients. Data were collected
and sent to the collecting institution (Universita Vita-Salute San Raffaele)
in an Excel (Microsoft Corporation, Redmond, Wash) format, including
age, preoperative serum creatinine value, EF, additive and logistic euro-
SCOREs, and operative mortality. Each institution received a code number
at the collecting institution. Data were subsequently sent to the analyzing
institution (San Donato Hospital) with the blinded code number.
At the analyzing institution, all data were merged into a single Excel file
and subsequently converted into an SPSS 13.0 (SPSS Inc, Chicago, Ill)
computerized statistical program that was used for all the statistical
calculations.
The ACEF score was calculated according to the equation1
ACEF score ¼ age ðyÞ=EFð%Þ
þ1 ðif preoperative serum creatinine value>2:0 mg=dLÞ:
The euroSCORE provides a direct evaluation of the operative mortality
risk; the operative mortality risk according to the ACEF score was calcu-
lated according to the logistic equation1
operative mortality risk ð%Þ ¼ 100 3 exp5:4þ 1:24 3 ACEF

1þexp 5:4þ 1:24 3 ACEF:
Model discrimination (accuracy) of the 3 predictive models was assessed
using a receiver operating characteristic analysis, producing an area under
the curve (AUC) with 95% confidence intervals (CIs). The same analysis
was repeated for the entire patient population and for subgroups of low-
risk (additive euroSCORE  2), medium-risk (additive euroSCORE
3–5), and high-risk (additive euroSCORE>5) patients.
Calibration and applicability (clinical performance) of the model were
assessed by comparing the observed mortality rate (% with 95% CI) with
the predicted mortality rate (%with 95%CI) for each of the 3 models. The
analysis was repeated for the entire patient population and for subgroups of
patients stratified to deciles according to the logistic euroSCORE-predicted
mortality.
RESULTS
Table 1 shows the characteristics of the patient popula-
tion. A total of 2956 patients (10%) were high risk (additive
euroSCORE> 10), with 2220 (7.5%) aged more than 80
years, 1270 (4.2%) with an EF less than 0.3, and 1003
(3.4%) with preoperative serum creatinine values greater
than 2.0 mg/dL.
A preliminary test of the linearity assumption for the re-
lationship age/EF versus mortality was performed, and the
hypothesis was confirmed with an r2 coefficient of 0.94 at
the linear regression between deciles of age/EF and mortal-
ity rate.
The observed mortality rate was 2.77%. The mortality
rate predicted by the ACEF score was 2.84%, which wasery c September 2011
TABLE 1. Characteristics of patient population (N ¼ 29,659)
Variable Mean SD 95% CI Range
Age (y) 66.6 11.6 66.5–66.7 19–93
Serum creatinine (mg/dL) 1.05 0.57 1.04–1.06 0.2–12
Left ventricle EF (%) 54.3 9.75 54.2–54.4 10–86
Additive euroSCORE 6.26 3.2 6.22–6.3 0–33
Logistic euroSCORE 9.67 10 9.56–9.79 0.8–99
ACEF score 1.32 0.48 1.32–1.33 0.17–7.3
ACEF score-predicted mortality (%) 2.84 3.66 2.79–2.88 0.5–97
Observed mortality (%) 2.77 0.16 2.59–2.96 –
SD, Standard deviation.
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The mortality rates predicted by the additive euroSCORE
(6.26%) and the logistic euroSCORE (9.67%) were signif-
icantly (P¼ .001) overestimated in comparison with the ob-
served mortality risk.
Receiver operating characteristic analysis (Figure 1)
demonstrated similar values of accuracy. The AUC was
similar in the 3 risk scores, 0.702 for the ACEF score,
0.692 for the logistic euroSCORE, and 0.687 for the addi-
tive euroSCORE, with overlapping 95%CIs. The odds ratio
for the ACEF score was 2.58 (95% CI, 2.35–2.83), with an
estimated operative mortality increase of 94% per each
ACEF score point.
To better assess the accuracy of the ACEF score and the
euroSCORE in different institutions, a further institution-
basedanalysiswasconducted (Table2).The institutions coded
1 and2provided a datasetwith 0%operativemortality. There-
fore, they could not be assessed for accuracy of the models.
In this analysis, data from the GVM hospitals are pooled to-
gether because they belong to the same central database.
The ACEF score demonstrated AUC values of 0.74 or moreFIGURE 1. Receiver operating characteristics analysis for the 3 models. ACE
dence interval.
The Journal of Thoracic and Cain 4 of the 5 institutions. There was a total lack of accuracy
of all models in 1 institution (with the highest mortality rate).
On exclusion of the 2 institutions that reported no opera-
tive mortality, in the remaining set of patients (27,174), the
best accuracy was obtained by the ACEF score (AUC 0.74),
followed by the logistic euroSCORE and the additive euro-
SCORE. In this subset, the odds ratio for the ACEF score
was 2.76 (95% CI, 2.52–3.01), with an estimated operative
mortality increase of 102% per each ACEF score point.
The predictive accuracy of the ACEF score was tested us-
ing a 10-fold cross-validation (Table 3), separately for the
whole population and the subset of patients obtained ex-
cluding the institutions without operative mortality. The ro-
bustness of the ACEF score was good in both settings
(overall population: mean AUCcv ¼ 0.699 vs mean
AUCone-shot ¼ 0.701; subset of institutions reporting
operative mortality: mean AUCcv ¼ 0.737 vs mean
AUCone-shot ¼ 0.74).
The clinical performance of the risk models is shown in
Figure 2. The patient population was divided in deciles ac-
cording to the logistic euroSCORE mortality risk. For each
decile, the observed operative mortality rate (with 95% CI)
and predicted mortality rate (with 95%CI) were calculated,
according to the additive euroSCORE, logistic euro-
SCORE, and ACEF.
Both the additive and logistic euroSCOREs significantly
overestimated the operative mortality risk in all deciles. The
ACEF score significantly overestimated the operative mor-
tality risk in the first decile (observed mortality rate, 0.3%;
95% CI, 0.1–0.6 vs predicted mortality rate, 1.5; 95% CI,
1.47–1.51) and the second decile (observed mortality rate,
0.8%; 95% CI, 0.5–1.1 vs predicted mortality rate, 1.8;
95% CI, 1.76–1.83). The ACEF score correctly estimatedF, Age, creatinine, ejection fraction; AUC, area under the curve; CI, confi-
rdiovascular Surgery c Volume 142, Number 3 583
TABLE 2. Accuracy of the predictive models in the different participating institutions
Institution
Patients
(n)
Operative
mortality (%)
ACEF score
AUC (95% CI)
euroSCORE (additive)
AUC (95% CI)
euroSCORE (logistic)
AUC (95% CI)
1 727 0 Not applicable Not applicable Not applicable
2 1,758 0 Not applicable Not applicable Not applicable
3 821 2.43 0.78 (0.67–0.89) 0.77 (0.67–0.86) 0.77 (0.67–0.87)
4 18,998 3.49 0.74 (0.71–0.75) 0.69 (0.67–0.71) 0.69 (0.67–0.71)
5 307 5.86 0.57 (0.46–0.68) 0.62 (0.51–0.74) 0.61 (0.49–0.72)
6 6,432 1.66 0.78 (0.74–0.82) 0.75 (0.71–0.79) 0.73 (0.68–0.77)
7 616 2.44 0.78 (0.65–0.91) 0.83 (0.73–0.93) 0.82 (0.72–0.93)
All institutions 29,659 2.77 0.70 (0.68–0.72) 0.68 (0.66–0.70) 0.69 (0.67–0.71)
Excluding institutions 1 and 2 27,174 3.02 0.74 (0.72–0.76) 0.70 (0.68–0.71) 0.71 (0.69–0.73)
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range, 1.4%–4.1%). The ACEF score significantly under-
estimated the operative mortality risk in the 10th decile (ob-
served mortality rate, 7.2%; 95% CI, 6.2–8.1 vs predicted
mortality rate, 5.52; 95% CI, 5.27–5.77).
DISCUSSION
Mortality after cardiac surgery is still a relevant issue,
and a clear definition of this event is still lacking. The con-
cept of ‘‘operative mortality’’ is based on in-hospital mor-
tality or outside-hospital mortality occurring within 30TABLE 3. Ten-fold cross-validation of the age, creatinine, ejection
fraction score
Overall population
Partition Frequency Percent
Cumulative
frequency
Cumulative
percent AUC
0 2965 10.00 2965 10.00 0.721
1 2966 10.00 5931 20.00 0.694
2 2966 10.00 8897 30.00 0.695
3 2966 10.00 11,863 40.00 0.688
4 2966 10.00 14,829 50.00 0.702
5 2966 10.00 17,795 60.00 0.687
6 2966 10.00 20,761 70.00 0.693
7 2966 10.00 23,727 80.00 0.701
8 2966 10.00 26,693 90.00 0.707
9 2966 10.00 29,659 100.00 0.705
Excluding institutions without operative mortality
Partition Frequency Percent
Cumulative
frequency
Cumulative
percent AUC
0 2717 10.00 2717 10.00 0.717
1 2717 10.00 5434 20.00 0.741
2 2718 10.00 8152 30.00 0.726
3 2717 10.00 10,869 40.00 0.717
4 2718 10.00 13,587 50.00 0.779
5 2717 10.00 16,304 60.00 0.742
6 2718 10.00 19,022 70.00 0.766
7 2717 10.00 21,739 80.00 0.698
8 2718 10.00 24,457 90.00 0.737
9 2717 10.00 27,174 100.00 0.747
584 The Journal of Thoracic and Cardiovascular Surgdays from the operation. This outcome measurement was
considered by the only 3 risk scores that are presently ac-
cepted (class I for euroSCORE and STS score, class IIb
for ACEF score) by the joint European Society of Cardiol-
ogy–European Association of Cardiac and Thoracic Sur-
gery Guidelines for Myocardial Revascularization.5
However, it should be considered that this interval is arbi-
trary, and that cardiac surgery-related mortality may extend
far beyond 30 days from the operation. More accurate risk
models with a different time-dependent outcome measure-
ment are suggested, but so far we can address this relevant
point using the existing tools.
The overall accuracy of the ACEF score in this external
validation series (AUC 0.7) is lower than in the internal val-
idation series (AUC 0.8).1 However, 2 institutions contrib-
uted a series of patients unsuitable for risk score
validation (no events), and when excluding these institu-
tions the accuracy increased to an acceptable AUC of
0.74. The ACEF score (and the euroSCORE) showed poor
performance in only 1 institution, which had the highest
mortality rate in our series.
According to our findings, the ACEF score performs bet-
ter than the widespread and established euroSCORE in pa-
tients undergoing elective cardiac surgery. In particular, we
confirmed the results of the first study introducing the
ACEF score1 in a larger patient population collected at mul-
tiple sites. In this series, the ACEF score has a noninferior
accuracy with respect to the additive and logistic euro-
SCOREs and a better clinical performance in elective pa-
tients. Despite being based on only 3 risk factors, the
ACEF score offers a level of accuracy comparable to
more complex scores based on more than 10 risk factors.
There are many possible explanations for this apparent par-
adox, which have been widely addressed in a previous
study1; however, it may be useful to remember that when
numerous variables are included in an attempt to ‘‘control’’
or ‘‘adjust’’ the data, the accuracy of the results may be
threatened,6 and the general advice of statisticians is to be
parsimonious in selecting independent variables.7 This con-
cept was recently8 applied to the euroSCORE, withery c September 2011
FIGURE 2. Predicted versus observed operative mortality rates for deciles of risk distribution. ACEF, Age, creatinine, ejection fraction; CI, confidence
interval; ES, European System for Cardiac Operative Risk Evaluation.
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does not increase if other factors are added to the first 5
most important risk factors: age, EF, preoperative creati-
nine, emergency operation, and non-isolated coronary oper-
ation. Conversely, there is a reduction in the related
calibration properties.
Our data confirm the well-known problem of operative
mortality risk overestimation attributable to the euroSCORE.
Therewas a 2- to 3-fold difference between the predicted and
the observed mortality when the prediction was based on the
additive and logistic euroSCOREs, respectively. The exis-
tence and magnitude of this discrepancy have been high-
lighted in other studies.9-15 The euroSCORE significantly
overestimated the operative mortality risk in every subset
of risk, with the highest discrepancy in the highest risk
decile, whereas the logistic euroSCORE predicted
a mortality 5-fold higher than that observed.
The mortality rate predicted by the ACEF score was not
significantly different from that observed for the entire pop-
ulation (with a negligible difference of 0.07%). Conversely,
therewas a significant overestimation in the 2 lowest deciles
of risk distribution, with a predicted mortality rate less than
2% and an observed mortality rate less than 1%. Although
significant, this difference is not important in clinical terms.
In very low-risk patients, the assumption that the predict-
able mortality is in the range of 1% to 2%may be accepted,
and subtle differences in this area are difficult to detect.
In the third to ninth deciles of risk distribution, the pre-
dicted mortality rate obtained by the ACEF score was not
significantly different from the observed mortality rate.
This observation pertains to an observed mortality risk
ranging from 1.4% to 4.1%, which is most representativeThe Journal of Thoracic and Cafor a population of adult patients undergoing elective car-
diac surgery.
In contrast with the euroSCORE, the ACEF score signif-
icantly underestimated the operative mortality risk in pa-
tients at high risk (10th decile, observed mortality rate
7.2%), with a predicted risk of 5.5%. Even if this differ-
ence may be considered acceptable in clinical terms,
some hypotheses derive from this pattern. First, 3 factors
are probably too few to predict the operative mortality in
very high-risk patients. A previous study8 demonstrated
that when the observed mortality rate is approximately
7%, adequate predictive models should include 7 to 12
risk factors. Second, there are issues related to the ‘‘ex-
treme’’ risk conditions. Some of the elective patients
who do not survive the operation actually die as a conse-
quence of 1 or more of these conditions, which may in-
clude severe chronic obstructive pulmonary disease under
oxygen therapy, morbid obesity (body mass index> 40),
neurologic impairment severely limiting the patient mobil-
ity, frailty, congenital prothrombotic or prohemorrhagic
disorders, and many others. None of these conditions is in-
cluded in any of the existing risk scores, and the ACEF
score is not an exception.
The ACEF score offers some advantages with respect to
the other existing risk scores. It is simple and based on num-
bers, not clinical conditions that may suffer from individual
interpretation and consequent operator-related biases. The
left ventricular EF is included as a continuous variable to
account for the extremely high risk attributable to patients
with EF in the range of 10% to 30%. In this area, the risk
increases exponentially with decreasing EF. The ACEF
score does not pool together all the patients with an EFrdiovascular Surgery c Volume 142, Number 3 585
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more patients with poor left ventricular EF are undergoing
cardiac operations, this feature of the ACEF score may be of
considerable importance.
A distinctive pattern of the ACEF score is that it is not
a broad measure and instead focuses exclusively on patients
undergoing elective cardiac surgery. The ACEF score does
not aim to predict risk in emergency clinical scenarios. This
may be seen as a limitation; however, the majority of the pa-
tients undergoing cardiac surgery are elective cases; more-
over, excluding critical scenarios is probably one of the
reasons for the improved clinical performance.
The most important finding of our study is that, in any
case, both the ACEF score and the euroSCORE failed to
reach optimal levels of accuracy (AUC> 0.8). Until the
problem of predicting mortality after cardiac surgery is ad-
dressed with the usual statistical approaches, it will always
be difficult to achieve this goal, regardless of the use of par-
simonious or complex models. The existence of rare, but
potentially lethal risk factors that are usually excluded by
logistic models is one of the main problems when trying
to individualize the risk prediction, and certainly many
high-risk patients may not receive a correct evaluation
with the existing risk models.
A limitation of the present study is that we compared the
ACEF score with the well-established additive and logistic
euroSCOREs, but we could not include the STS-predicted
risk of mortality (PROM) score in the comparison. The
STS-PROM is a well-performingmodel that includes a con-
siderable number of risk factors, with different calculations
based on the type of operation. This algorithm underlying
the STS-PROM score is not available, and therefore retro-
spective calculations are impossible.
CONCLUSIONS
Our study confirms that a simple risk score may offer the
same accuracy and better clinical performance than more
complex scores in the setting of patients undergoing elective
cardiac surgery. The ACEF score may be a good starting
point for further studies in the field of risk stratification in car-
diac surgery and should be considered as a simple ‘‘skeleton’’
to build up different models that apply to different clinical
scenarios, which is actually what the cardiologists did
when they integrated the ACEF and Syntax scores.2 The pre-
viouslymentioned ‘‘extreme’’risk conditions that are usually
left outside the risk scores because of their low prevalence
may be tested one by one or in combination to increase the
performance of the ACEF score in the area of high-risk oper-
ations. Further improvements of the ACEF score could be
based on statistical techniques that differ from the usual
logistic regression analysis and test potential additional fac-
tors to increase the ‘‘risk stratification capacity’’ for the586 The Journal of Thoracic and Cardiovascular Surgdetectionof specific high-riskpatient populations (eg, patient
selection for transcatheter aortic valve implantation) with
risk-stratification tables.16,17 The present validation study
justifies the inclusion of the ACEF score within the existing
risk stratification scores in cardiac surgery,5 opening the
door to possible further improvements of this model.
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